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INTRODUCTION
Traumatic brain injury is a frequently recorded 
case in the Emergency Department. Traumatic 
brain injury is one of the main causes of death in 
the range of productive age. Globally traumatic 
brain injury incidents are increasing sharply due to 
increased use of motor vehicles. According to World 
Health Organization (WHO) estimates, by 2020 
traffic accidents will be the third most prevalent 
cause of illness and trauma in the world. Every year 
about 5.3 million Americans suffer brain injuries. 
While in Europe in 2010 the incidence of traumatic 
brain injury reached 500 per 100,000 population. 
Traumatic brain injury is a mechanical trauma that 
directly or indirectly affects the head which can 
lead to impaired neurological function, even death. 
In general, traumatic brain injury results from 
motor vehicle accidents, attacks or crimes, violent 
blows, gunfire, or improper movement during 
exercise. An awareness level assessment is import-
ant in patients with traumatic brain injury because 
the level of consciousness is one of the parameters 
important for clinicians in making decisions when 
determining therapy or intervention. Accuracy in 
the assessment of the degree of awareness is very 
important because if there is a mistake in determin-
ing the degree of awareness it will be able to influ-
ence the management of therapy and also outcome 
from the patient.1
The BIS Monitor, a tool that used to objectively 
assess the level of awareness, was introduced 
in 1994 by Aspect Medical Systems (USA) as a 
modality to measure the level of patient awareness 
during general anesthesia based on the bispectral 
analysis of electroencephalogram (EEG). BIS values 
range from 0 (isoelectric signals) to 100 (conscious 
patients). The depth of anesthesia that is considered 
sufficient for surgery ranges from 40-60. The use of 
current BIS monitors has also been widespread in 
the Intensive Care Unit (ICU) to monitor the effects 
of sedation. Patients with Traumatic brain injuries 
lead to disability and even death, so it is deemed 
necessary to assess outcomes in  brain-injured 
patients treated in hospital. The final outcome 
assessment of patients with head injuries is using 
Glasgow Outcome Scale (GOS) and extended 
Glasgow outcome scale (GOSE). Assessment using 
GOS and GOSE is gaining popularity and is often 
used in developed and developing countries to 
assess the outcomes of patients with brain injury 
who are treated in hospital.2
Functional measurement scales commonly 
used in TBI patients
There are a wide number of scales that have been 
developed to assess function, handicap, and disabil-
ity following TBI. These ‘functional’ scales aim to 
assess objectively the burden that TBI may impose 
on a patient’s life. We conducted a MEDLINE 
search of studies involving assessment of functional 
and quality of life outcomes in patients with TBI 
to identify the most commonly used assessment 
scale. Glasgow Outcome Scale (GOS) and extended 
Glasgow Outcome Scale (GOSe) originally 
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ABSTRACT
Traumatic brain injury (TBI) is a major public health issue, which results 
in significant mortality and long-term disability. The profound impact 
of TBI is not only felt by the individuals who suffer the injury but also 
their caregivers and society as a whole. Clinicians and researchers 
require reliable and valid measures of long-term outcome not only to 
truly quantify the burden of TBI and the scale of functional impairment 
in survivors but also to allow early appropriate allocation of 
rehabilitation supports. In addition, clinical trials which aim to improve 
outcomes in this devastating condition require high-quality measures 
to accurately assess the impact of the interventions being studied. In 
this article, we review the properties of an ideal measure of outcome 
in the TBI population. Then, we will describe the measurement tools 
include: the Glasgow Outcome Scale (GOS) and extended Glasgow 
Outcome Scale (GOSe) in correlation with bispectral index (BIS).
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described in 1975, the Glasgow Outcome Scale 
(GOS) has become the most widely used method 
for classifying outcome in TBI survivors.3 It is used 
by both acute care and rehabilitation specialists to 
assess recovery.4 The GOS is a multi-dimensional 
scale which assesses various aspects of outcome 
(i.e., consciousness; independence; work status; 
return of lifestyle). The five categories of the orig-
inal GOS scale are: (i) dead; (ii) vegetative (cannot 
interact, unresponsive) and (iii) severely disabled 
(can follow commands, cannot live independently); 
moderately disabled (can live independently, 
reduced work capacity) and good recovery (can 
work).5 The output from the scale is frequently 
dichotomised into unfavorable (dead, vegetative 
and severely disabled) versus favorable (moderately 
disabled and good recovery) outcomes. The scale 
reflects the impact of the TBI on the patient’s level 
of functioning. The GOS has proven as a useful and 
simple measure and has been used in many clinical 
trials to assess outcomes in patients with moderate 
and severe TBI.6
Despite its widespread use, the GOS is increas-
ingly recognized to have a number of important 
inadequacies, some of which relate to the simplicity 
of the scale.7 These limitations include a perceived 
allocation bias in the higher functional end of the 
scale, evidence of systematic bias between differ-
ent professional groups administering the scale, 
and the ‘open ended’ and unstructured format of 
the interview used by some. These shortcomings 
have led to speculation that the GOS is insensi-
tive to small (but clinically relevant) changes in 
functional status.8 These concerns about loss of 
sensitivity in part lead to the development of an 
extended version of the scale (GOSe) which sepa-
rates each of the three higher function categories 
into two, making eight categories in total. It has 
been prospectively demonstrated that the validity 
(criterion) of the GOSe generally exceeds the GOS 
and it is more sensitive to change than the GOS.7 
Outcomes as determined by the GOSe are strongly 
associated with outcome category on numerous 
alternative functional scales. These findings lend 
further support for utilization of the GOSe over 
the original GOS in clinical trials. Many of the 
other previous criticisms of both the GOS and 
GOSe have been addressed by the development of 
a structured interview process; under these condi-
tions the GOS and GOSe have good reliability7 
in patients with TBI. The reliability of this scale 
when administered by phone call (as opposed to 
face-to-face interview) is an additional feature 
which increases the practical usefulness of this 
measure. A recent expert workshop sponsored by 
the National Institute of Neurological Disorders 
and Stroke recommended the use of the GOSe as 
the gold standard outcome measure in future TBI 
trials. However, the optimal method of analysis 
of the GOS/GOSe has been more controversial. 
While it is widely acknowledged that the dichot-
omization of any scale reduces its sensitivity, the 
majority of studies continue to use the dichoto-
mized version of the GOS/GOSe as their primary 
outcome measure. Many feel that it is better to 
exploit the ordinal nature of the GOS/GOSe scales 
and relate the outcome to the risk for individual 
patients. Two different approaches for this are the 
proportional odds analysis model (estimate of the 
shift in outcome across the GOS/GOSe scale) and 
the sliding dichotomy (the point of the dichotomy 
of the GOS/GOSe is differentiated according to the 
baseline risk estimated in each individual patient). 
Initial reports of the use of these methods have 
been encouraging, and have led to recommenda-
tions for future clinical trials to switch from the 
conventional dichotomized GOS/ GOSe analysis 
to these newer models.9
It is clear that the earlier an outcome tool can 
be reliably and validly used to assess a cohort of 
patients the more useful it will be, not only to give 
early information to caregivers but also to prevent 
drop-out and loss to follow-up in clinical trials. 
However, the use of any tool in patients with TBI 
needs not only to balance these logistic demands 
but also to recognize that a reasonable period of 
time is needed for improvement and stabilization 
of recovery before assessment. Most studies have 
used the GOS/GOSe at 6–12 months post injury. 
While there may be a small change in the propor-
tion of patients with good recovery at 6–12 months, 
the dichotomised ‘favorable’ versus ‘unfavorable’ 
outcome has generally stabilized at this stage.32 
While it is recognized that this 6–12 months assess-
ment may not be the ‘final’ outcome state it is used 
by many studies which assume that any disability 
persisting at this stage is permanent or life-long. 
This point is important when one is tracking recov-
ery. It is also important to note that changes in 
outcome in an individual patient between 6 months 
and 1–2 years post injury may reflect the level 
and quality of rehabilitation support rather than 
the deficit from the initial injury. This is a finding 
which is important to document especially in the 
context of multi-national clinical trials where the 
quality of rehabilitation could differ significantly. 
Conversely, it also vital to recognize the potential 
bias introduced when very early assessments (i.e., 
GCS) are made to predict long-term outcomes 
after TBI, given the potential confounding effects 
of inadequate volume resuscitation and alcohol 
intoxication.3
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Bispectral Index (BIS)
During the evolution of modern anesthesia 
practice, the assessment of anesthetic depth in 
patients has undergone gradual changes and 
improvement. Observation of previous anesthesia 
depth from clinical signs such as pupil response, 
respiratory pattern, pulse quality plus direct 
measurement of physiological endpoints includ-
ing blood pressure, heart rate and respiratory rate 
and respiratory volume. With the development of 
pulse oximetry and capnography, proper assess-
ment of ventilation management is enforceable. 
The use of end-tidal and peripheral nerve stim-
ulation give the anesthesiologist the ability to 
measure the concentration of pharmacological 
agents and the effects of each drug. Currently, 
heart function can be evaluated using advanced 
technology of pulmonary artery catheters and 
transesophageal echocardiography (TEE) for 
new methods of continuous blood pressure and 
cardiac monitoring.10
Despite the remarkable developments in the 
assessment of cardiovascular systems during 
anesthesia, the direct determination of the effects 
of anesthesia and sedative on the central nervous 
system remains a challenge. Careful clinical inves-
tigation shows that the hemodynamic response 
does not always provide an accurate represen-
tation of the central nervous system response to 
anesthetic agents and therefore unreliability of 
brain status indicators. In contrast, a technology 
that will allow independent neurophysiological 
monitoring of the central nervous system will 
provide a direct measure of brain status during 
anesthesia and sedation, allowing physicians to 
perfect perioperative management and achieve 
the best outcomes for each patient. Accurate 
monitoring and targeting effects on the brain, 
in combination with traditional clinical assess-
ment and monitoring assessments, will enable a 
more complete approach to adjusting doses and 
mixtures of anesthesia, sedatives and analgesic 
agents.11
The Bispectral Index Monitor (BIS) initially 
appears to assist professional anesthesiologists 
as a direct and accurate method of continuously 
monitoring brain activity throughout the course 
of anesthesia and surgery. BIS monitors are 
considered capable of providing measurements 
on the hypnotic effects of anesthetic drugs. BIS 
is the first tool capable of quantitatively provid-
ing an EEG picture. BIS tools consist of sensors, 
digital signal modifiers, and monitors. The sensor 
is placed on the patient’s forehead to pick up elec-
trical signals from the cerebral cortex and trans-
fer them to the digital signal changes. This BIS 
monitor is able to integrate various mark of EEG 
into single variable. Artifacts on BIS may occur 
when there is electrical activity arising from 
sources other than the brain, such as other body 
parts (eg eye movements and jaw movements), 
environment, or equipment.10,11
It has been known for decades that EEG changes 
in response to the effects of anesthesia. Although 
each drug can induce some unique effects on the 
EEG, the overall pattern of EEG wave changes is 
very similar to each other. One of the primary 
goals in developing brain-status monitoring tech-
nology is to identify EEG features that are strongly 
associated with sedation or hypnosis caused by 
commonly used anesthetic agents. In its develop-
ment, this BIS can then also be used to monitor 
brain electrical activity in patients treated in ICU, 
predicting neurological outcomes of patients, 
giving Picture the level of awareness in patients 
with traumatic brain injury, and estimate prog-
nosis in coma patients, BIS scores are considered 
capable of reflecting the functional status of the 
cerebral cortex.11
The numbers appearing on the BIS monitor 
are obtained by utilizing a mixture of various EEG 
signal processing techniques including bispectral 
analysis, spectral power analysis, and time domain 
analysis. These steps are combined through an algo-
rithm to optimize the correlation between EEG and 
clinical effects of anesthesia. Due to the sophisti-
cated and intricate process of this analysis, the score 
that appears on the BIS monitor does not reflect the 
condition of brain activity in real time. There is a 
delay time of approximately 15-30 seconds of signal 
acquisition until the BIS score of the data appears 
on the BIS monitor.12 
The BIS index is the result of processing of 
BIS algorithms. The bispectral analysis is part 
of the cortical EEG picture that describes the 
changes that occur in the relationship between 
the neural generators in cortical and subcortical. 
If the cortical-sub-cortical relationship is altered, 
then there will be a change of pattern on the EEG. 
The bispectral analysis has a complex method of 
signal processing that assesses the relationships 
between the components that change due to the 
change in received signal and then synchronizes 
the changes in the signal. By quantifying the rela-
tionship between all frequencies generated by the 
signal, the bispectral analysis is capable of gener-
ating additional descriptors of EEGs that describe 
brain activity during the hypnotic phase. BIS 
algorithm obtained from the observation of more 
than 5000  subjects who get a particular hypnotic 
agent. Various modalities are used to assess the 
sedation effects of the drug simultaneously. One 
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of the key modalities in the assessment is the EEG 
picture. From these observations, it is hoped that 
the discovery of one or more key features (also 
called ‘predictors’) is strongly correlated with 
sedation or hypnosis. Data of observation result 
are then  analyzed with multivariate test to assess 
correlation among variables.12
Research by Paul and Rao in 2006, found that 
BIS has a significant correlation to GCS in cases 
of traumatic brain injury (r = 0.67, p <0.001). 
The average BIS score is reported to increase as 
the GCS score increases. The mean value of BIS 
in CKR patients was 65.7 ± 16.1 and in CKS was 
86.7 ± 6.1. While Jung (2013) found that the mean 
values of BIS in comatose, semi-coma, stupor, and 
drowsiness were seen respectively 0.14 ± 0.23, 
38.9  ± 18.0, 60.3 ± 14.5, And 73.6 ± 16.5. This 
suggests that the use of BIS is not only limited 
to anesthesia but may also be used to assess the 
extent of brain electrical activity in traumatic 
brain injury patients. If the correlation between 
BIS and GCS is strong, then the reporting and 
communication process between future medical 
personnel will be universal and more objective 
than using GCS scores alone.13
Correlation Glasgow outcome scale and 
bispectral index
Many studies say there is a significant relationship 
between the value of BIS and GOS / GOSE. Hana 
et al, have studied 25 patients ages 18-75 (av. 36) 
y. Head injury was severe (initial GCS < or = to 
8 in 18 patients, and moderate (initial GCS 9-12) 
in 7 patients. Daily assessment included GCS and 
BIS evaluation during the first-week post-injury. 
Glasgow outcome scale (GOS) was used to assess 
outcome at discharge. GOS scores were compared 
to average BIS (obtained from the area under the 
curve for BIS x time/total time) for 7 days post 
injury and av. GCS for 7 days post injury. Daily 
BIS values were also compared to simultaneously 
recorded GCS. Data were analyzed by Spearman 
rank correlation analysis; GOS was ranked as 1 to 
5  for good recovery (GR), moderate disability 
(MD), severe disability (SD), persistent vegetative 
state (PVS), and death, respectively. There were 
strong correlations between GOS and BIS. BIS 
>or=to 60  was associated with good outcome, 
whereas, an av. BIS <or=to 40 was associated with 
poor outcome.14
Conclusion 
It is clear that many patients suffer significant 
disability following TBI. There are a number of 
scales which are commonly used to assess disability, 
impairment, and function as well as the quality of 
life measures. The GOSe at 6 months is the most 
reliable, validated and commonly used functional 
outcome measurement scale in randomized 
controlled trials of patients following TBI. In addi-
tion, the conventional straight dichotomy analytic 
technique, whilst more commonly utilized, is less 
sensitive than either the proportional odds or 
sliding dichotomy techniques, which are likely to 
become the standard in the future. A valid measur-
ing instrument and can objectively measure the 
level of consciousness before assessed the outcome 
after getting therapy is bispectral index. Many stud-
ies have suggested a positive correlation between 
BIS and GCS in measuring awareness of patients 
with traumatic brain injury, and a strong correla-
tion between BIS score and GOS score so that BIS 
can predict the outcome of patients with traumatic 
brain injury.
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